Japan Drug Makers Driven by Overseas Sales, See Tepid Revenue at Home: Jiho Tally

Combined sales of 27 Japanese drug makers landed a year-on-year rise of 3.3% in April-September, a Jiho tally shows. With their performance being lackluster in Japan, however, the overall uptick was driven primarily by their revenues overseas. The tally covered...read more